Sort by
Keyphrases
Metastasis
100%
Aryl Hydrocarbon Receptor
100%
Neuroblastoma
100%
Kynurenine
100%
Kiss1
36%
Overexpression
27%
Cell Differentiation
18%
Tumor Growth
9%
Poor Prognosis
9%
Cell Proliferation
9%
Histology
9%
Strong Correlation
9%
Therapeutic Target
9%
Clinical Significance
9%
Receptor Expression
9%
Malignant Disease
9%
Mouse Xenograft Model
9%
Immunostaining
9%
Neuroblastoma Tumor
9%
New Therapeutics
9%
Therapeutic Potential
9%
Genomic Analysis
9%
Visualization Platform
9%
Patient Tumor
9%
Prognostic Indicator
9%
Xenograft Model
9%
Novel Prognostic Biomarker
9%
Differentiation in Vitro
9%
Tumor Metastasis Suppressor
9%
MYCN Oncogene
9%
Endogenous Ligand
9%
Genome Visualization
9%
Medicine and Dentistry
Metastatic Carcinoma
100%
Ganglioneuroblastoma
100%
Aromatic Hydrocarbon Receptor
100%
Kynurenine
100%
Cell Differentiation
18%
Xenograft
18%
Tumor Progression
9%
In Vitro
9%
Neoplasm
9%
Oncogene
9%
Biological Marker
9%
Receptor Expression
9%
Cell Proliferation
9%
Immunohistochemistry
9%
Patient with Neuroblastoma
9%
Infancy
9%
Clinical Significance
9%
Metastasis Suppressor
9%
Diseases
9%
Immunology and Microbiology
Xenograft
100%
Cell Differentiation
100%
Cell Proliferation
50%
Infancy
50%
Immunostaining
50%
Prognostic Biomarker
50%
Oncogene
50%
Neuroscience
Neuroblastoma
100%
Aryl Hydrocarbon Receptor
100%
Kynurenine
100%
Cellular Differentiation
18%
In Vitro
9%
In Vivo
9%
Immunohistochemistry
9%
Cell Proliferation
9%
Receptor Expression
9%
Oncogene
9%
Metastasis Suppressor
9%
Biochemistry, Genetics and Molecular Biology
Aryl Hydrocarbon Receptor
100%
Kynurenine
100%
Cellular Differentiation
18%
Tumor Progression
9%
Oncogene
9%
Cell Proliferation
9%
Immunostaining
9%
Infancy
9%
Metastasis Suppressor
9%
Genomics
9%